摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methylsulfanylhexan-3-amine

中文名称
——
中文别名
——
英文名称
N-methylsulfanylhexan-3-amine
英文别名
——
N-methylsulfanylhexan-3-amine化学式
CAS
——
化学式
C7H17NS
mdl
——
分子量
147.28
InChiKey
XPOVJTROYBZPQP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    9
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Treatment of skin lesions and pruritus in prurigo nodularis patients
    申请人:GALDERMA HOLDING SA
    公开号:US11236157B2
    公开(公告)日:2022-02-01
    Disclosed herein are methods for selectively treating pruritus in a subject having chronic prurigo (CP), including prurigo nodularis (PN), pharmaceutical compositions for use in the treatment of pruritus in a subject having CP or PN, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of pruritus in a subject having CP or PN.
    本文公开了选择性治疗慢性瘙痒症(CP)(包括结节性瘙痒症(PN))患者瘙痒症的方法、用于治疗CP或PN患者瘙痒症的药物组合物、在制造治疗CP或PN患者瘙痒症的药物中使用尼妥珠单抗或其等效物的方法。
  • TREATMENT OF SKIN LESIONS AND PRURITUS IN PRURIGO NODULARIS PATIENTS
    申请人:CHUGAI SEIYAKU KABUSHIKI KAISHA
    公开号:US20200239563A1
    公开(公告)日:2020-07-30
    Disclosed herein are methods for selectively treating pruritus in a subject having chronic prurigo (CP), including prurigo nodularis (PN), pharmaceutical compositions for use in the treatment of pruritus in a subject having CP or PN, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of pruritus in a subject having CP or PN.
查看更多

同类化合物

甲磺酸 N,N-二甲基-2,2-二甲基乙烷次磺酰胺 2-甲基异噻唑烷 2-氰基-2-五氟苯基丁酸乙酯 N-methyl-N-tert.-octylthiomethylamine hydrochloride N-methyl-N-ethylthiomethylamine hydrochloride N-methyl-N-isopropylthiomethylamine hydrochloride perfluoro-2-methyl-1-cyclopenten-N,N-diethylsulfenamide 2-β-hydroxyethylthioethylamine hydrochloride 2-Amino-aethan-1-sulfensaeure N,N'-bis(1,1,1,2,3,3,3-heptafluoropropan-2-ylsulfanyl)-N,N'-dimethylethane-1,2-diamine N-[(1,1,2,2-Tetrachloroethyl)sulfanyl]methanamine 2-methyl-3,6-dihydro-1,2-thiazine N,N-dibutyl-hexane-1-sulfenamide N-[2-(dimethylaminosulfanyl)ethylsulfanyl]-N-methylmethanamine N-(butylthio)-tert-butylamine 1,1-dimethyl-ethanesulfenic acid dibutylamide N-Methylmethansulfenamid N-(tert-butylthio)ethylamine N-(tert-butylthio)butylamine N-(tert-butylthio)cyclohexylamine N,N-Dimethyl-2-chlortetrafluoraethansulfenamid N-<2-(Methlthio)-ethylthio>-dimethylamin N,N-Di-n-butylmethansulphenamid nonafluoro-n-butanesulfenic acid N-(Chlormethylthio)diethylamin N-[2-[2-[ethyl(methyl)amino]sulfanylethoxy]ethylsulfanyl]-N-methylethanamine N-ethyl-N-methyl-hexanesulfenamide N-(tert-butylthio)methylamine 2-isopropyl-4,5-dimethyl-3,6-dihydro-1,2-thiazine N-(Chlormethylthio)dimethylamin N-[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]sulfanyl-N-methylmethanamine N-(Propan-2-yl)-N-(propylsulfanyl)propan-2-amine N-Ethyl-N-(propylsulfanyl)ethanamine N,N-dipropyl-propane-1-sulfenamide 2-methyl-N-(2-methylpropyl)-N-propylsulfanylpropan-1-amine N-Butylpropanesulfenamide N,N-diethylmethanesulfenamide 1-Chlor-N-(1,1,3,3-tetramethylbutyl)-1,1-bis(trifluormethyl)methansulfenamid N-(1-Adamantyl)-1-chlor-1,1-bis(trifluormethyl)methansulfenamid N-(tert-butylthio)isopropylamine 4-Propyl-1,3,4-oxathiazinane (5Z)-3-(methylsulfanylamino)-5-[(Z)-prop-1-enyl]nona-1,5-dien-2-olate N-ethyl-N-ethylsulfanyl-2-(methylideneamino)ethenamine 4,4-Dichloro-3-octylidene-1,2-thiazolidine N,2-dimethyl-N-methylsulfanylpentan-1-amine (1R,2R)-1,2-bis(hydroxysulfanyl)ethane-1,2-diol 2-(Methylaminosulfanyl)ethanamine 2-Ethyl-3-hydroxysulfanylbutan-1-ol 2-ethyl-2-methyl-N-(5-methylhexyl)-N-methylsulfanylhexan-1-amine